Published in Thyroid on February 02, 2012
Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2007) 4.66
Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2012) 4.64
Direct control of shoot meristem activity by a cytokinin-activating enzyme. Nature (2007) 3.27
An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid (2003) 3.23
An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg (2010) 2.81
Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy. World J Surg (2010) 2.75
Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid (2013) 2.66
Electrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery: international standards guideline statement. Laryngoscope (2011) 2.55
Surgical complications of posterior lumbar interbody fusion with total facetectomy in 251 patients. J Neurosurg Spine (2006) 2.11
BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients. Endocr J (2008) 2.06
Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis. Cancer Res (2002) 2.02
Thermodilution-derived coronary blood flow pattern immediately after coronary intervention as a predictor of microcirculatory damage and midterm clinical outcomes in patients with ST-segment-elevation myocardial infarction. Circ Cardiovasc Interv (2014) 1.99
Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy. Thyroid (2011) 1.96
Four cases of Graves' disease which developed after painful Hashimoto's thyroiditis. Intern Med (2006) 1.90
Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells. Pharmacogenet Genomics (2005) 1.85
Our experience of treatment of cribriform morular variant of papillary thyroid carcinoma; difference in clinicopathological features of FAP-associated and sporadic patients. Endocr J (2011) 1.72
A mutant high-density lipoprotein receptor inhibits proliferation of human breast cancer cells. Cancer Res (2004) 1.67
Risk factors for adjacent segment degeneration after PLIF. Spine (Phila Pa 1976) (2004) 1.65
Usefulness of thyroglobulin measurement in fine-needle aspiration biopsy specimens for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer. World J Surg (2005) 1.63
Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg (2006) 1.63
Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J Surg (2007) 1.58
Palatal mucosal measurements in a Japanese population using cone-beam computed tomography. J Esthet Restor Dent (2013) 1.55
Surgical strategy for cervical myelopathy due to ossification of the posterior longitudinal ligament: Part 2: Advantages of anterior decompression and fusion over laminoplasty. Spine (Phila Pa 1976) (2007) 1.54
Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid. Endocr J (2008) 1.53
Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade. FEBS J (2006) 1.49
Thyrotoxicosis caused by weight-reducing herbal medicines. Arch Intern Med (2005) 1.49
Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab (2007) 1.49
Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily. Thyroid (2009) 1.48
Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease. Clin Endocrinol (Oxf) (2009) 1.47
Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up. World J Surg (2012) 1.47
Serum concentrations of granulocyte colony-stimulating factor (G-CSF) in antithyroid drug-induced agranulocytosis. Endocr J (2004) 1.46
Surgical strategy for cervical myelopathy due to ossification of the posterior longitudinal ligament: Part 1: Clinical results and limitations of laminoplasty. Spine (Phila Pa 1976) (2007) 1.46
Mutational analysis of the APC gene in cribriform-morula variant of papillary thyroid carcinoma. World J Surg (2006) 1.46
Third molar position: reliability of panoramic radiography. J Oral Maxillofac Surg (2007) 1.45
Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients. World J Surg (2012) 1.43
Cone-beam CT with flat-panel-detector digital angiography system: early experience in abdominal interventional procedures. Cardiovasc Intervent Radiol (2006) 1.42
Transient hyperthyroidism after withdrawal of antithyroid drugs in patients with Graves' disease. Endocr J (2004) 1.41
External branch of the superior laryngeal nerve monitoring during thyroid and parathyroid surgery: International Neural Monitoring Study Group standards guideline statement. Laryngoscope (2013) 1.40
Environmental sex determination in the branchiopod crustacean Daphnia magna: deep conservation of a Doublesex gene in the sex-determining pathway. PLoS Genet (2011) 1.39
Increased serum concentration of eosinophil-derived neurotoxin in patients with Graves' disease. Thyroid (2003) 1.39
Ernest L. Mazzaferri, MD, MACP (1936-2013). Thyroid (2013) 1.39
Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg (2006) 1.39
CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin alpha5beta1. FEBS Lett (2006) 1.38
A deubiquitinating enzyme UBPY regulates the level of protein ubiquitination on endosomes. Traffic (2006) 1.38
Improvement in phonation after reconstruction of the recurrent laryngeal nerve in patients with thyroid cancer invading the nerve. Surgery (2009) 1.37
Identification of the nuclear receptor CAR:HSP90 complex in mouse liver and recruitment of protein phosphatase 2A in response to phenobarbital. FEBS Lett (2003) 1.37
Distinct diagnostic criteria for ultrasonographic examination of papillary thyroid carcinoma: a multicenter study. Thyroid (2005) 1.36
A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid. Nat Clin Pract Endocrinol Metab (2007) 1.35
Distinct clinical, serological, and sonographic characteristics of hashimoto's thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab (2010) 1.34
FINE CULM1 (FC1) works downstream of strigolactones to inhibit the outgrowth of axillary buds in rice. Plant Cell Physiol (2010) 1.33
SNPs in the promoter of a B cell-specific antisense transcript, SAS-ZFAT, determine susceptibility to autoimmune thyroid disease. Hum Mol Genet (2004) 1.32
Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J Surg (2006) 1.32
Recovery of parathyroid function after total thyroidectomy: long-term follow-up study. ANZ J Surg (2005) 1.30
Surgical outcomes of posterior lumbar interbody fusion in elderly patients. J Bone Joint Surg Am (2006) 1.29
Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma. Ann Surg (2011) 1.28
Effects of loss of steroid receptor coactivator-1 on the skeletal response to estrogen in mice. Endocrinology (2003) 1.28
Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg (2004) 1.26
Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg (2005) 1.25
Characteristics of accessory mental foramina observed on limited cone-beam computed tomography images. J Endod (2008) 1.24
Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid. World J Surg (2004) 1.24
Establishment of an intraoperative staging system (iStage) by improving UICC TNM classification system for papillary thyroid carcinoma. World J Surg (2010) 1.22
The FOXE1 and NKX2-1 loci are associated with susceptibility to papillary thyroid carcinoma in the Japanese population. J Med Genet (2011) 1.20
Development of an RNA interference method in the cladoceran crustacean Daphnia magna. Dev Genes Evol (2011) 1.20